Table 1

Clinical characteristics of patients suspected to have COVID-19

Patients (n=21)
Age (years)
 Mean (SD)43.1 (2.6)
 Range24–61
Sex, n (%)
 Female12 (57.1)
 Male9 (42.9)
Comorbidities, n (%)8 (38.1)
 Cardiovascular diseases3 (14.3)
 Digestive disease4 (19.0)
 Endocrine disease1 (4.8)
 Respiratory disease1 (4.8)
Respiratory symptoms, n (%)
 No symptom5 (23.8)
 One symptom8 (38.1)
 More than one symptom8 (38.1)
Identifying the patients, n (%)
 Abnormalities on chest CT before onset of respiratory symptoms12 (57.1)
 Abnormalities on chest CT after onset of respiratory symptoms4 (19.0)
 Abnormalities on chest CT without respiratory symptoms5 (23.8)
Abnormalities on chest CT, n (%)
 Unilateral10 (47.6)
 Bilateral11 (52.4)
RT-PCR test, n (%)
 Positive1 (4.8)
 Negative20 (95.2)
Routine blood test, n (%)
 Leucopenia11 (52.4)
 Lymphocytopaenia9 (42.9)
Respiratory treatment, n (%)
 Antiviral treatment21 (100)
 Antibiotic treatment21 (100)
 Intravenous antibiotic therapy4 (19.0)
Psychiatric treatment adjustment after detection of chest CT findings, n (%)14 (66.7)
 Increase of the types or doses11 (52.4)
 Increased benzodiazepines6 (28.6)
 Decrease of the types or doses3 (14.3)
  • RT-PCR, reverse transcription PCR.